敲除 / 敲低 / 敲入 / 过表达稳转细胞系与敲除细胞裂解物，按「基因 × 细胞系」粒度提供，支持定制建株。 共 1,221 个产品。
eGFP/Luciferase BCMA Knockout RPMI-8226 Cell Line enables multimodal myeloma studies with fluorescence visualization and bioluminescent quantification.
A stable monoclonal cell line expressing EGFR(L858R-C797S) was established using lentiviral technology based on BAF3 cells.
A monoclonal cell line stably expressing EGFR constructed using viral technology based on CHO-K1 cells.
A monoclonal cell line stably expressing EGFR constructed using viral technology based on HEK293 cells.
EGFR WT BAF3 Cell Line enables kinase inhibitor studies by replacing IL-3 dependency in BA/F3 cells, supporting research on receptor tyrosine kinases.
EGFR(A763-Y764-ins-FQEA-C797S) BAF3 Cell Line supports drug resistance research and mechanistic studies of EGFR mutations in targeted therapies.
EGFR(A763-Y764insFQEA-T790M) BAF3 Cell Line supports EGFR mutation studies, cancer biology research, and targeted therapy drug screening in vitro.
EGFR(D770_N771insSVD-T790M) BAF3 Cell Line, Stable BAF3 cells expressing mutant EGFR for research on EGFR-driven signaling and drug testing.
A monoclonal cell line stably expressing EGFR constructed using viral technology based on BAF3 cells.
A stable monoclonal cell line expressing EGFR (Del19-C797S) was established using lentiviral technology based on BAF3 cells.
EGFR(Del19-T790M-C797S) BAF3 Cell Line serves as a drug-resistant EGFR mutation model for cancer signaling studies and targeted therapy development.
EGFR(Del19-T790M-L718Q) BAF3 Cell Line offers a model for studying EGFR mutations and targeted therapies in cancer research and drug resistance studies.
EGFR Del19/T790M/L718V triple mutant BAF3 line suited for testing TKI resistance, novel inhibitor screening, and preclinical lung cancer therapy research.
EGFR(H773_V774insNPH-T790M) BAF3 cell line for research on oncogenic EGFR signaling, drug resistance, and targeted therapy studies in vitro.
A monoclonal cell line stably expressing EGFR(L747S-T790M-C797S) constructed using viral technology based on BAF3 cells.
EGFR(L858R-L718V)BAF3 Cell Line is a mutant model for studying EGFR-driven signaling, targeted cancer therapies, and oncogenic pathway research in vitro.
EGFR(L858R-T790M-C797S) BAF3 Cell Line supports drug-resistant EGFR studies, targeted therapy research, and cancer biology investigations in vitro.
EGFR(L858R-T790M-L718Q) BAF3 Cell Line provides a model for studying EGFR-driven signaling, targeted therapy, and oncogenic mutation research in vitro.
EGFR(L858R-T790M-L718V) BAF3 Cell Line models resistant EGFR mutations, supporting cancer drug discovery, therapeutic evaluation, and pathway analysis.
EGFR(L858R-T790M) BAF3 Cell Line provides a resistant EGFR mutant model, ideal for cancer biology, drug screening, and targeted therapy development.
A stable monoclonal cell line expressing EGFR(T790M-C797S) was established using lentiviral technology based on BAF3 cells.
EGFR(T790M-L861Q) BAF3 Cell Line provides a drug-resistant cancer model to study EGFR mutations, targeted therapy response, and signaling mechanisms.
EGFR(V769-D770insASV-T790M) BAF3 Cell Line serves as a validated EGFR mutation model for drug resistance, oncology research, and therapy development.
A monoclonal cell line stably expressing ENPP3(CD203c) constructed using viral technology based on CHO-K1 cells.
共 1,221 个产品 ｜ 第 13 / 51 页
